Animal models

Mouse in drug discovery research
#Animal models #Drug discovery #Genetically engineered models (GEMs) #Humanisation #Humanised Immune System (HIS) #Mouse models

Elevating drug discovery through access to in vivo models

This paid-for advertorial by Taconic Biosciences appeared in DDW Volume 25 – Issue 3, Summer 2024. Harnessing the power of sophisticated GEMs and humanized mice is essential to moving research forward. In the dynamic landscape of drug discovery, the utilisation of high-quality animal models is paramount for success. Among these models,… Read More

#Exclusive Content

Child with cystic fibrosis on ventilator
#Animal models #Cystic fibrosis #Enterprise Therapeutics #Preclinical development

ENaC blocker enhances mucus clearance in cystic fibrosis models

A preclinical study in cystic fibrosis sheep models has demonstrated that low doses of the ENaC blocker ETD001 can enhance airway mucus clearance with a long duration of action. The study indicates that ETD001, at a dose level that was well tolerated in healthy volunteers, provides… Read More

#News

Mouse in laboratory
#Animal models #Charles River #Preclinical development #Sanofi

New project hopes to reduce the use of animals in drug research

Charles River Laboratories has announced the launch of its Virtual Control Groups (VCG) initiative with Sanofi. The companies are working together to reduce animal usage by replacing selected control group animals with selected matched virtual control animals developed using retrospective datasets. The VCG collaboration… Read More

#News

Lab mouse
#Animal models #Animal testing #Charles River #Preclinical development

Charles River launches initiative to reduce animal testing

Charles River Laboratories International has launched its Alternative Methods Advancement Project (AMAP), an initiative focused on developing alternatives to reduce animal testing. The company has invested $200 million over the past four years to reduce the use of animal testing and has a five-year goal of… Read More

#News

#Animal models #Interview #Sitting Down With #The Jackson Laboratory #Vodcast

Watch the latest DDW vodcast

The latest DDW Sitting Down With sponsored vodcast is now available. It features Dr Adriano Flora, Director of Business Development at The Jackson Laboratory (JAX). In this vodcast, he discusses alternatives to non-human primates, the key benefits of this, and what impact will they have on the future of… Read More

#News

Medicine concept
#AI / data analytics / healthtech / informatics #Animal models #Drug discovery #Genetics / genomics #Synthetic biology

Why have medicines progressed so little in the last decades?

Dr Pandora Pound, Fellow Oxford Centre for Animal Ethics explores the hinderances of animal testing in pharma and why new technologies such AI, genomics and synthetic biology can further drug development.  There was great fanfare recently for a new Alzheimer’s drug, lecanemab (brand name Leqembi), which was shown in a… Read More

#Exclusive Content #Opinion

Human antibodies
#Animal models #Antibodies #HIV #Immunology / Virology & Vaccines #NIAID

Antibodies protect against HIV in animal studies

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV vaccine for people. The antibodies – a human broadly neutralsing antibody and two antibodies isolated from previously vaccinated monkeys – target… Read More

#News

Lab mouse
#Animal models #Drug discovery #Mouse models #Taconic

More efficient mouse model generation through informed founder selection

This paid-for advertorial by Taconic appeared in DDW Volume 24 – Issue 3, Summer 2023 Overcoming challenges in model generation Genetically engineered mouse models are essential tools for biomedical research. Yet when seeking to obtain an existing model, researchers often encounter obstacles related to intellectual property, availability, or licensing. As a… Read More

#Exclusive Content

#Animal models #Cancer immunotherapy #Cell therapy #Covid-19 #Humanised Immune System (HIS) #Immunotherapy #Monoclonal antibodies #Mouse models #Oncology #Regulatory

Podcast: Immunotherapy, avelumab and the immunocompromised

This is the latest episode of the free DDW narrated podcast, “Immunotherapy, avelumab and protecting the immunocompromised”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Mice with humanised immune systems advance cell-based immunotherapy”, “… Read More

#News

Lightbulb, ideas, innovation
#AI #Animal models #Animal testing #BioInnovation Institute #Data science #Drug discovery #Drug research #Microbiome #Regulatory

New podcast: Innovate to reinvent the future of drug discovery

This is the latest episode of the free DDW narrated podcast, “Innovating now to reinvent the future of drug discovery”. It covers three articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Predictive biomarkers in the… Read More

#News

Cancer Research UK Beatson Institute
#Animal models #Cancer research #Cancer Research UK #Cancer Research UK Beatson Institute #ELRIG #Events #Human disease models #Scotland #University of Glasgow

Scottish drug discovery: Advancing new research models

Following the Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provides a snapshot of drug discovery in Scotland. With over 150 pharma services/supply companies and 19 universities, Scotland is one of the most advanced life science sectors in the UK and the world. To demonstrate how Scotland is… Read More

#Exclusive Content

Innovation
#Advanced Therapies #Animal models #Autoimmune disease #Cell and gene therapy #Data #Genetics / genomics #Immunology #Pharma

New podcast on animal genomics, immunology and CGTs

This is the latest episode of the free DDW narrated podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Can animal genomics help find… Read More

#News

#Animal models #Animal testing #Assays #Drug development #Drug discovery #Mouse models

Accelerating NDA filing through faster carcinogenicity assessment

Dr Megan MacBride and Dr Caroline Horizny Mitchell, Taconic, examine recent changes to animal testing in drug design. Drug discovery and development is an arduous process that can cost upwards of $2.6 billion and take over 10 years. While the discovery phase – which includes target discovery, target validation, lead… Read More

#Exclusive Content

Animal testing
#Animal models #Animal testing #Cancer research #Human disease models #Oncology #Preclinical development

Closing the translation gap in oncology drug development

Jantzen Sperry, PhD, Director of Scientific Operations at Certis Oncology looks at how the adoption of orthotopic PDX models can elevate the impact of cancer research and improve translation in oncology drug development. The recent passage of the FDA Modernization Act, which removed the requirement for animal testing when suitable… Read More

#Cancer Research #Exclusive Content

Cancer immunotherapy
#Animal models #Cancer research #Immunotherapy #Mouse models #Taconic

Immunotherapy advancements with humanised immune system mouse models

This article is sponsored by Taconic. The cancer therapeutic landscape changed dramatically with the introduction of immune checkpoint inhibitors (ICIs) that target T cells and leverage a patient’s immune system. Success in targeting T cells as immunotherapy has prompted investigators to explore whether other immune cell… Read More

#News